Seoul Pharma Co., Ltd (KOSDAQ:018680)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,315.00
-60.00 (-1.78%)
At close: Aug 1, 2025, 3:30 PM KST

Seoul Pharma Company Description

Seoul Pharma Co., Ltd manufactures and sells pharmaceutical products in South Korea and internationally.

The company offers orally disintegrating film products for therapeutic areas, including urology, neurology, nutrition, endocrinology, and OB/GY.

Its products include VULTEUM and VULTIS for erectile dysfunction; ARTPEZIL for Alzheimer’ disease; OBCARE to treat overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency; and CH.V, as well as products for schizophrenia, vitamin supplement, obesity, tonic, and menopausal syndrome.

The company also provides Ator for high blood pressure treatment; Flavel to treat stroke; Axated, a peptic ulcer medication; Crestin to treat hyperlipidemia; and Weltmin and Fendigene for the treatment of obesity.

It also owns patents to orally dispersible films. The company was founded in 1976 and is headquartered in Cheongju-si, South Korea.

Seoul Pharma Co., Ltd
CountrySouth Korea
Founded1976
IndustryPharmaceutical Preparations
Employees172
CEOHei Youn Hwang

Contact Details

Address:
124-31, Osongsaengmyeong 6-ro
Cheongju-si, 281 58
South Korea
Phone82 43 715 5800
Websiteseoulpharma.com

Stock Details

Ticker Symbol018680
ExchangeKOSDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyKRW
SIC Code2834

Key Executives

NamePosition
Hei Youn HwangChief Executive Officer